BridgeBio Pharma Other Long Term Liabilities (Quarterly) Insights

BridgeBio Pharma, Inc. (BBIO)

68.82 +0.91 (+1.34%) USD | NASDAQ | Feb 24, 13:04

View Other Long Term Liabilities (Quarterly) for BBIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Mirum Pharmaceuticals, Inc.	Upgrade
Cogent Biosciences, Inc.	Upgrade
Alnylam Pharmaceuticals, Inc.	Upgrade
Sarepta Therapeutics, Inc.	Upgrade